Acylcholine acyl-hydrolase, E.C. 3.1.1.8, the plasma enzyme still most often referred to as pseudocholinesterase exists as genetic variants. The atypical pseudocholinesterase, which can cause suxamethonium sensitivity in some individuals, can be differentiated from the usual enzyme by means of inhibitory substances. The principle of differentiation by inhibitors is based upon the use of an inhibitor at a concentration at which the difference in inhibition between the usual and the atypical enzyme is the largest possible.
Different substances have been used to detect suxamethonium-sensitive individuals and to characterize genetic variants of the atypical pseudocholinesterase. The inhibitors most frequently used have been dibucaine (Kalow and Genest, 1957) , fluoride (Harris and Whittaker, 1961) , chloride (Whittaker, 1963) , and substance Ro 2-0683 (Liddell, Lehmann and Davies, 1963) .
In addition to the above-mentioned substances, urea can be employed to detect atypical pseudocholinesterase. During investigation of two Danish families with atypical pseudocholinesterase we met difficulties in the classification of the genotypes of the family members employing the above inhibitors (Hanel and Viby Mogensen, 1970) . We therefore tried to inhibit the enzyme with urea, which appeared to be a valuable aid in our case.
MATERIAL AND METHODS

Laboratory investigations.
Blood samples from members of the two mentioned Danish families, in which we previously studied the distribution of atypical pesudocholinesterase, were used. In addition, blood samples from suxamethonium-sensitive patients from the hospital department of anaesthetics were investigated. The pedigrees of the families are published elsewhere (Hanel and Viby Mogensen, 1971) . All investigations were performed on serum, which was kept at 4°C for a maximum of 7 days.
For the measurement of pseudocholinesterase activity, the procedure of Kalow and Genest (1957) was used. In a recording spectrophotometer, thermostated at 25 °C, the change in light absorbance at 240 nm was plotted against reaction time. Activity was then calculated from the slope of the straight line obtained as [jimoles of benzoylcholine split per minute. The activity was calculated per litre of serum, (U/l.).
Genetic variants of atypical pseudocholinesterase were characterized by the following methods: dibucaine number (Kalow and Genest, 1957) , fluoride number (Harris and Whittaker, 1961) , chloride number (Whittaker, 1968) , and Ro 2-0633 (dimethyl carbonate of (2-hydroxy-5-phenyl-benzyl) trimethyl (ammonium bromide) (Liddell, Lehmann and Davies, 1963) . Inhibition of pseudocholinesterase by urea was studied by measuring the activity of the enzyme in serum at different known concentrations of urea in the final incubation mixture. The loss of activity at a given urea concentration was expressed as a percentage of the activity in the absence of urea. The molar urea activity was then plotted against the precentage of inhibition. 
RESULTS
The percentage urea inhibitions of pseudocholinesterase for 10 normal homozygotes, 6 heterozygotes, and 3 atypical homozygotes are shown in figure 1. The curves in figure 1 represent means of each homozygous group (mean ±2SD). The pseudocholinesterases of the patients were found by inhibition studies to be of the genotypes, E^E^, E^E,", and E/E^, according to the nomenclature proposed by Motulsky (1964) . A 50 per cent inhibition of the pseudocholinesterase of the genotype E^E^ was achieved at about 5 molar, and of the genotype EfEf at about 2 molar urea concentration as shown in figure 1.
DISCUSSION
Urea inhibition can be used for differentiation between usual and atypical pseudicholinesterases. As can be seen from figure 1, at a 2-3 molar urea concentration, the inhibition for individuals of the genotype E/E,* was about 55-60 per cent, whereas for individuals of the genotype E^Ej" the inhibition was about 20-32 per cent. Individuals of the genotype E^E/ were between these two values, but they cannot be distinguished from the normal group.
Higher urea concentrations would give greater differences between the atypical and the typical enzymes but would increase the technical difficulties in the measurement of the low activity, especially of the atypical pseudocholinesterase.
It has been shown that urea can cause an unfolding of the chains in the protein structure, which gives rise to an increased volume of the protein molecule, because its polypeptide structure becomes less compact (Nozaki and Tanford, 1963; Tanford, 1964) . Olesen and Pedersen (1963) found by gel filtration of human albumin at different urea concentrations an increase of a part of the protein molecules, probably due to stepwise unfolding or swelling of albumin, indicating a stepwise denaturation of the protein.
The urea inhibition of pseudocholinesterase activity may thus be caused by the same mechanisms. As the effect is more pronounced on the atypical than on the usual enzyme, this might indicate that the usual enzyme is more stable in its tertiary protein structure than is the atypical. Similar results were obtained by Brandt and Hanel (1971) 
RESUMKN
Es descrito un nuevo mitodo para difercnciar entre las seudocolinesterasas usual y atipka en el suero mediante uso de urea. Este metodo puede ser utilizado para detectar los individuos sensible) al suxametonio. Los resultados de estudios de la inhibkion de urea indican que la seudocoUnesterasa adpica es menos estabk en su estructura de proteuia terciaria que la enzimn usual.
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